Kimia Biosciences Limited (BOM:530313)

India flag India · Delayed Price · Currency is INR
36.18
-1.32 (-3.52%)
At close: Apr 28, 2026
-10.02%
Market Cap 1.71B
Revenue (ttm) 1.26B
Net Income (ttm) 90.52M
Shares Out 47.31M
EPS (ttm) 1.91
PE Ratio 18.94
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,637
Average Volume 8,545
Open 37.50
Previous Close 37.50
Day's Range 36.00 - 38.47
52-Week Range 23.20 - 86.85
Beta 0.89
RSI 57.77
Earnings Date May 26, 2026

About Kimia Biosciences

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its prod... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1993
Employees 250
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530313
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.